Skip to main content
Log in

In Vitro Dissolution Profile of Water-Insoluble Drug Dosage Forms in the Presence of Surfactants

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

The determination of the in vitro release profile of water-insoluble drug products requires dissolution media different from those used for water-soluble drug products. Since the relevance of drug dissolution in organic solvents is questionable, we investigated the use of surfactants to determine the dissolution profiles of water-insoluble drug products. In most cases, the drug dissolution rate and extent increased as the surfactant concentration in the aqueous dissolution medium increased. Suitable dissolution profiles were obtained in the presence of sodium lauryl sulfate (SLS) for water-insoluble drug products, such as griseofulvin, carbamazepine, clofibrate, medroxyprogesterone, and cortisone acetate. These findings recommend the use of surfactants for determining the aqueous dissolution of water-insoluble drug products rather than adding organic solvents to the dissolution medium.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. J. P. Skelly. J. Clin. Pharmacol. 16:539–543 (1976).

    Google Scholar 

  2. M. Gibaldi and S. Feldman. J. Pharm. Sci. 56:1238–1242 (1967).

    Google Scholar 

  3. B. Katchen and S. Symchowicz. J. Pharm. Sci. 56:1108–1111 (1967).

    Google Scholar 

  4. S. Symchowicz and B. Katchen. J. Pharm. Sci. 57:1383–1386 (1968).

    Google Scholar 

  5. W. L. Chiou and S. Riegelman. J. Pharm. Sci. 59:937–942 (1970).

    Google Scholar 

  6. W. D. Walkling, R. K. Nayak, J. Plostnieks, and W. A. Cressman. Drug Dev. Indust. Pharm. 5(1):17–27 (1979).

    Google Scholar 

  7. T. J. Goehl, G. M. Sundaresan, and V. K. Prasad. Int. J. Pharm. 11:181–186 (1982).

    Google Scholar 

  8. G. Levy. J. Pharm. Sci. 50:388–392 (1961).

    Google Scholar 

  9. J. G. Wagner, P. D. Holmes, P. K. Wilkinson, D. C. Blair, and R. G. Stoll. Am. Rev. Resp. Dis. 108:536–546 (1973).

    Google Scholar 

  10. FDA. FDA Division of Bioequivalence Guidance for in vivo Bioequivalence Study in vitro Dissolution Testing for Carbamazepine Tablets (Sept. 30, 1987).

  11. H. Schott, L. C. Kwan, and S. Feldman. J. Pharm. Sci. 71:1038–1045 (1982).

    Google Scholar 

  12. T. R. Bates, M. Gibaldi, and J. L. Kanig. Int. J. Pharm. 55:191–199 (1966).

    Google Scholar 

  13. B. Gander, K. Ventouras, R. Gurny, and E. Doelker. Int. J. Pharm. 27:117–124 (1985).

    Google Scholar 

  14. USP. Pharmacop. Forum 14(3):3893 (1988).

    Google Scholar 

  15. P. Buri and J. Humbert-Droz. 3rd Int. Cong. Pharm. Techn. Paris 4:136–143 (1983).

    Google Scholar 

  16. G. E. Amidon, W. I. Higuichi, and N. F. Ho. J. Pharm. Sci. 71:77–84 (1982).

    Google Scholar 

  17. H. M. Abdou. Remington's Pharmaceutical Sciences, 17th ed. Mack Publishing, Easton, Pennsylvania, 1985, pp. 653–666.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shah, V.P., Konecny, J.J., Everett, R.L. et al. In Vitro Dissolution Profile of Water-Insoluble Drug Dosage Forms in the Presence of Surfactants. Pharm Res 6, 612–618 (1989). https://doi.org/10.1023/A:1015909716312

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015909716312

Navigation